Key result
Extracellular vesicles drive vascular dysfunction and thrombosis, emerging as potential biomarkers or therapeutics.
Why the study?
Atherosclerotic cardiovascular disease remains the leading cause of morbidity and mortality worldwide, with emerging evidence highlighting extracellular vesicles as key mediators of intercellular communication in immunoinflammation and atherothrombosis.
Extracellular vesicles play a dual role in atherothrombosis, driving both disease progression and vascular repair, highlighting their potential as biomarkers and therapeutic targets.
Answers are grounded in this paper and cite their sources.
May inform EV biomarker development in atherothrombosis; leaves open therapeutic translation pending prospective trials.
Atherosclerotic cardiovascular disease is the leading cause of morbidity and mortality all over the world. Extracellular vesicles (EVs), small lipid-bilayer membrane vesicles released by most cellular types, exert pivotal and multifaceted roles in physiology and disease. Emerging evidence emphasizes the importance of EVs in intercellular communication processes with key effects on cell survival, endothelial homeostasis, inflammation, neoangiogenesis, and thrombosis. This review focuses on EVs as effective signaling molecules able to both derail vascular homeostasis and induce vascular dysfunction, inflammation, plaque progression, and thrombus formation as well as drive anti-inflammation, vascular repair, and atheroprotection. We provide a comprehensive and updated summary of the role of EVs in the development or regression of atherosclerotic lesions, highlighting the link between thrombosis and inflammation. Importantly, we also critically describe their potential clinical use as disease biomarkers or therapeutic agents in atherothrombosis.
No takes yet. Share an insight, caveat, or question.
Suades et al. (2022) conducted a review in Atherothrombosis. Extracellular vesicles was evaluated. Extracellular vesicles act as key signaling molecules that drive immunoinflammation, vascular dysfunction, and thrombus formation, with potential clinical applications as biomarkers or therapeutics.
Synapse has enriched 10 related papers. Consider them for comparative context: